| Title |
Thalidomide-Revisited: Are COVID-19 Patients Going to Be the Latest Victims of Yet Another Theoretical Drug-Repurposing?
|
|---|---|
| Published in |
Frontiers in immunology, May 2020
|
| DOI | 10.3389/fimmu.2020.01248 |
| Pubmed ID | |
| Authors |
Athar Khalil, Amina Kamar, Georges Nemer |
X Demographics
The data shown below were collected from the profiles of 42 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 14% |
| United Kingdom | 6 | 14% |
| Canada | 2 | 5% |
| Lebanon | 2 | 5% |
| Switzerland | 2 | 5% |
| Germany | 1 | 2% |
| Ireland | 1 | 2% |
| Australia | 1 | 2% |
| Poland | 1 | 2% |
| Other | 1 | 2% |
| Unknown | 19 | 45% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 36 | 86% |
| Scientists | 5 | 12% |
| Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 149 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 149 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 21 | 14% |
| Student > Ph. D. Student | 13 | 9% |
| Other | 13 | 9% |
| Student > Master | 12 | 8% |
| Student > Doctoral Student | 10 | 7% |
| Other | 38 | 26% |
| Unknown | 42 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 38 | 26% |
| Nursing and Health Professions | 13 | 9% |
| Biochemistry, Genetics and Molecular Biology | 11 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 5% |
| Chemistry | 4 | 3% |
| Other | 25 | 17% |
| Unknown | 50 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 73. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 December 2023.
All research outputs
#609,687
of 26,184,649 outputs
Outputs from Frontiers in immunology
#557
of 33,037 outputs
Outputs of similar age
#18,639
of 433,649 outputs
Outputs of similar age from Frontiers in immunology
#23
of 706 outputs
Altmetric has tracked 26,184,649 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 33,037 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,649 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 706 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.